GAMA
LKFT

Graticule Asia Macro Advisors’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Graticule Asia Macro Advisors’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-41,818
Closed -$3.2M – 97
2017
Q2 		$3.2M Buy
41,818
+1,818
+5% +$153K 0.15% 80
2017
Q1 		$3.45M Buy
+40,000
New +$2.88M 0.2% 82
2015
Q4 		– Sell
-50,000
Closed -$2.04M – 181
2015
Q3 		$2.04M Buy
+50,000
New +$2.88M 0.24% 50

Other funds holding LKFT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Graticule Asia Macro Advisors's LKFT Position: Q3 2017 in Review

Graticule Asia Macro Advisors sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q3 2017, closing a stake of 41,818 shares — an estimated $3.2M sold.

Graticule Asia Macro Advisors first reported a position in LKFT in Q3 2015 and held it in 3 quarters. The position peaked at $3.45M in Q1 2017. 69 funds tracked by Wall St. Rank hold LKFT as of Q3 2017.

  • Graticule Asia Macro Advisors reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q3 2017 after selling out during the quarter.
  • Graticule Asia Macro Advisors sold 41,818 Lakefront Biotherapeutics American Depositary Shares shares in Q3 2017, an estimated $3.2M.
  • Graticule Asia Macro Advisors first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2015 and held it in 3 quarters.
  • Graticule Asia Macro Advisors's Lakefront Biotherapeutics American Depositary Shares position peaked at $3.45M in Q1 2017.
  • 69 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2017.

Based on Graticule Asia Macro Advisors's 13F filing for Q3 2017, filed 13 Nov 2017.